FDA — authorised 26 June 1986
- Application: NDA018959
- Marketing authorisation holder: HOSPIRA
- Local brand name: ZINC CHLORIDE IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Gingilacer Encías Delicadas Colutorio in United States
FDA authorised Gingilacer Encías Delicadas Colutorio on 26 June 1986
Marketing authorisations
FDA — authorised 21 May 2021
- Application: ANDA212007
- Marketing authorisation holder: EXELA PHARMA
- Local brand name: ZINC CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 16 October 2024
- Application: ANDA216152
- Marketing authorisation holder: SOMERSET
- Local brand name: ZINC CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 14 April 2025
- Application: ANDA217625
- Marketing authorisation holder: STIRA
- Local brand name: ZINC CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
Frequently asked questions
Is Gingilacer Encías Delicadas Colutorio approved in United States?
Yes. FDA authorised it on 26 June 1986; FDA authorised it on 21 May 2021; FDA authorised it on 16 October 2024.
Who is the marketing authorisation holder for Gingilacer Encías Delicadas Colutorio in United States?
HOSPIRA holds the US marketing authorisation.